THE DEAL, AT A GLANCE
From the announcementAlp Bio
01Who is involvedBacked by ["42cap", "Venture Kick", "strategic angel investors"]From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedAlp Bio raised Pre-Seed, announced 2026-07-03From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersALP Bio is using pre-seed funding to advance an immune organoid and generative AI platform intended to predict immunogenicity risks in biologics earlier in antibody…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Alp Bio · Financing Record
Explore source-linked visual explanations for Alp Bio. Unsupported claims are withheld while source review continues.
Record 7247 · Recorded date: 2026-07-03
Explore company records →